1. Home
  2. DNLI vs RQI Comparison

DNLI vs RQI Comparison

Compare DNLI & RQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • RQI
  • Stock Information
  • Founded
  • DNLI 2013
  • RQI 2002
  • Country
  • DNLI United States
  • RQI United States
  • Employees
  • DNLI N/A
  • RQI N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • RQI Trusts Except Educational Religious and Charitable
  • Sector
  • DNLI Health Care
  • RQI Finance
  • Exchange
  • DNLI Nasdaq
  • RQI Nasdaq
  • Market Cap
  • DNLI 2.1B
  • RQI 1.7B
  • IPO Year
  • DNLI 2017
  • RQI N/A
  • Fundamental
  • Price
  • DNLI $14.04
  • RQI $12.53
  • Analyst Decision
  • DNLI Strong Buy
  • RQI
  • Analyst Count
  • DNLI 15
  • RQI 0
  • Target Price
  • DNLI $33.85
  • RQI N/A
  • AVG Volume (30 Days)
  • DNLI 1.7M
  • RQI 432.6K
  • Earning Date
  • DNLI 07-31-2025
  • RQI 01-01-0001
  • Dividend Yield
  • DNLI N/A
  • RQI 8.20%
  • EPS Growth
  • DNLI N/A
  • RQI N/A
  • EPS
  • DNLI N/A
  • RQI N/A
  • Revenue
  • DNLI N/A
  • RQI N/A
  • Revenue This Year
  • DNLI N/A
  • RQI N/A
  • Revenue Next Year
  • DNLI $335.74
  • RQI N/A
  • P/E Ratio
  • DNLI N/A
  • RQI N/A
  • Revenue Growth
  • DNLI N/A
  • RQI N/A
  • 52 Week Low
  • DNLI $10.57
  • RQI $9.17
  • 52 Week High
  • DNLI $33.33
  • RQI $12.64
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 48.38
  • RQI 54.26
  • Support Level
  • DNLI $13.83
  • RQI $12.21
  • Resistance Level
  • DNLI $14.66
  • RQI $12.65
  • Average True Range (ATR)
  • DNLI 0.63
  • RQI 0.18
  • MACD
  • DNLI -0.03
  • RQI -0.00
  • Stochastic Oscillator
  • DNLI 31.58
  • RQI 62.00

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About RQI Cohen & Steers Quality Income Realty Fund Inc

COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the Fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.

Share on Social Networks: